Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-17

Clinical Trial Update: A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy of CellCept (mycophenolate mofetil) in lupus nephritis was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED | Results posted: 2014-07-17